OXFORD, U.K. and MARLBOROUGH, Mass., March 31, 2015 -- Oxford Immunotec Global PLC , a global, commercial-stage diagnostics company focused on developing and commercializing proprietary tests for the management of immune-regulated conditions, today announced the availability in the United States of a new test that measures the strength of a patient's cellular immune response to cytomegalovirus . This T-SPOT .
http://ift.tt/1GdxdNY
http://ift.tt/1GdxdNY
No comments:
Post a Comment